BioStem Technologies, Inc. (BSEM)
4.68
-0.18
(-3.66%)
USD |
OTCM |
Apr 15, 16:00
BioStem Technologies Research and Development Expense (Annual) : 7.086M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Plus Therapeutics, Inc. | 8.379M |
| Iovance Biotherapeutics, Inc. | 300.27M |
| Protokinetix, Inc. | 0.0996M |
| GB Sciences, Inc. | -- |
| Travere Therapeutics, Inc. | 206.01M |